Robert Klugman
Biographic Data
| ID | 5540369 |
|---|---|
| NAME | Robert Klugman |
| GIVEN NAMES | Robert |
| FAMILY NAME | Klugman |
| SIGNATURE | KLUGMAN R |
| AFFILIATIONS | Kindred Healthcare, Wellesley, MA |
| VERIFIED | No |
| TOTAL WORKS | 2 |
| TOTAL CITATIONS | 0 |
| WORKS AS AUTHOR | 2 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2017 |
| LATEST PUBLICATION YEAR | 2023 |
| H-INDEX | 0 |
The mobile vaccine equity enhancement program–a model program for enhancing equity in vaccine availability based at a large health care system
The SARS CoV-2 (COVID-19) pandemic presented unprecedented challenges as communities attempted to respond to the administration of a novel vaccine that faced cold chain logistical requirements and vaccine hesitancy among many, as well as complicated phased rollout plans that changed frequently as availability of the vaccine waxed and waned. The COVID-19 pandemic also disproportionately affected communities of color and communities with barriers t…
Measuring Harm in Health Care
OBJECTIVE: The objective of this study was to identify modifiable factors that improve the reliability of ratings of severity of health care-associated harm in clinical practice improvement and research. METHODS: A diverse group of clinicians rated 8 types of adverse events: blood product, device or medical/surgical supply, fall, health care-associated infection, medication, perinatal, pressure ulcer, surgery. We used a generalizability theory fr…
No prominent works on this page.
Measuring Harm in Health Care
OBJECTIVE: The objective of this study was to identify modifiable factors that improve the reliability of ratings of severity of health care-associated harm in clinical practice improvement and research. METHODS: A diverse group of clinicians rated 8 types of adverse events: blood product, device or medical/surgical supply, fall, health care-associated infection, medication, perinatal, pressure ulcer, surgery. We used a generalizability theory fr…
The mobile vaccine equity enhancement program–a model program for enhancing equity in vaccine availability based at a large health care system
The SARS CoV-2 (COVID-19) pandemic presented unprecedented challenges as communities attempted to respond to the administration of a novel vaccine that faced cold chain logistical requirements and vaccine hesitancy among many, as well as complicated phased rollout plans that changed frequently as availability of the vaccine waxed and waned. The COVID-19 pandemic also disproportionately affected communities of color and communities with barriers t…
Health care (2 works) · Medicine (2 works) · Business (1 work) · COVID-19 epidemiological studies (1 work) · Disease (1 work) · Economic growth (1 work) · Economics (1 work) · Ethics in medical practice (1 work) · Family medicine (1 work) · Generalizability theory (1 work)